OptimizeRx Stock Price, News & Analysis (OTCMKTS:OPRX)

$1.59 0.13 (8.90 %)
(As of 01/16/2018 04:00 PM ET)
Previous Close$1.52
Today's Range$1.48 - $1.60
52-Week Range$0.63 - $1.62
Volume26,721 shs
Average Volume12,055 shs
Market Capitalization$42.74 million
P/E Ratio-22.71
Dividend YieldN/A
Beta1.1

About OptimizeRx (OTCMKTS:OPRX)

OptimizeRx logoOptimizeRx Corporation is a technology solutions company. The Company focuses on the healthcare industry. The Company connects patients, physicians and pharmaceutical manufacturers through technology. The Company's solutions provide pharmaceutical manufacturers a direct to physician channel for communicating and promoting products. It provides healthcare providers a means to provide sampling and coupons without having to physically store samples on site. The Company's principal products and applications include SampleMD, OPTIMIZEHR and OPTIMIZERx.com. SampleMD is a virtual Patient Support Center. OPTIMIZEHR is a consulting practice focused on educating and working with pharmaceutical manufacturers on identifying, formulating and implementing new electronic prescribing (eRx) media strategies for promoting their products. OPTIMIZERx.com is a portal to healthcare savings for patients to centrally review and participate in prescription and healthcare savings and support programs.

Receive OPRX News and Ratings via Email

Sign-up to receive the latest news and ratings for OPRX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorComputer and Technology
SymbolOTCMKTS:OPRX
CUSIPN/A
Phone248-651-6568

Debt

Debt-to-Equity RatioN/A
Current Ratio2.12%
Quick Ratio2.12%

Price-To-Earnings

Trailing P/E Ratio-22.7110412798172
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$7.75 million
Price / Sales6.01
Cash FlowN/A
Price / CashN/A
Book Value$0.26 per share
Price / Book6.12

Profitability

Trailing EPS($0.07)
Net Income$-1,530,000.00
Net Margins-21.33%
Return on Equity-32.46%
Return on Assets-20.82%

Miscellaneous

Employees20
Outstanding Shares29,270,000

OptimizeRx (OTCMKTS:OPRX) Frequently Asked Questions

What is OptimizeRx's stock symbol?

OptimizeRx trades on the OTCMKTS under the ticker symbol "OPRX."

How were OptimizeRx's earnings last quarter?

OptimizeRx Co. (OTCMKTS:OPRX) posted its quarterly earnings data on Thursday, November, 2nd. The technology company reported ($0.02) earnings per share (EPS) for the quarter. OptimizeRx had a negative return on equity of 32.46% and a negative net margin of 21.33%. View OptimizeRx's Earnings History.

When will OptimizeRx make its next earnings announcement?

OptimizeRx is scheduled to release their next quarterly earnings announcement on Wednesday, March, 14th 2018. View Earnings Estimates for OptimizeRx.

Who are some of OptimizeRx's key competitors?

Who are OptimizeRx's key executives?

OptimizeRx's management team includes the folowing people:

  • Gus D. Halas, Chairman of the Board (Age 66)
  • Miriam Paramore, President (Age 54)
  • William J. Febbo, Chief Executive Officer (Age 47)
  • Douglas P. Baker CPA, Chief Financial Officer, IR Contact Officer (Age 59)
  • Brian J. Dillon, Senior Vice President - Product and Strategy
  • Terence J. Hamilton, Vice President - Sales, Director (Age 50)
  • James Paul Lang, Director
  • Jack T. Pinney M.D., Director (Age 59)
  • Lynn O'Connor Vos, Director (Age 60)

How do I buy OptimizeRx stock?

Shares of OptimizeRx can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is OptimizeRx's stock price today?

One share of OptimizeRx stock can currently be purchased for approximately $1.59.

How big of a company is OptimizeRx?

OptimizeRx has a market capitalization of $42.74 million and generates $7.75 million in revenue each year. The technology company earns $-1,530,000.00 in net income (profit) each year or ($0.07) on an earnings per share basis. OptimizeRx employs 20 workers across the globe.

How can I contact OptimizeRx?

OptimizeRx's mailing address is 400 WATER STREET SUITE 200, ROCHESTER MI, 48307. The technology company can be reached via phone at 248-651-6568 or via email at [email protected]


MarketBeat Community Rating for OptimizeRx (OPRX)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  45 (Vote Outperform)
Underperform Votes:  68 (Vote Underperform)
Total Votes:  113
MarketBeat's community ratings are surveys of what our community members think about OptimizeRx and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

OptimizeRx (OTCMKTS:OPRX) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyN/AN/A
Consensus Rating Score: 3.003.00N/AN/A
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/AN/AN/AN/A
Price Target Upside: N/AN/AN/AN/A

OptimizeRx (OTCMKTS:OPRX) Consensus Price Target History

Price Target History for OptimizeRx (OTCMKTS:OPRX)

OptimizeRx (OTCMKTS:OPRX) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
10/30/2017Lake Street CapitalInitiated CoverageBuyView Rating Details
(Data available from 1/16/2016 forward)

Earnings

OptimizeRx (OTCMKTS:OPRX) Earnings History and Estimates Chart

Earnings by Quarter for OptimizeRx (OTCMKTS:OPRX)

OptimizeRx (OTCMKTS OPRX) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/14/2018        
11/2/2017Q3 2017($0.02)ViewN/AView Earnings Details
8/1/2017Q2 2017($0.01)$2.87 millionViewListenView Earnings Details
5/3/2017Q1 2017($0.03)$2.15 millionViewListenView Earnings Details
3/8/2017Q4 2016($0.01)ViewN/AView Earnings Details
11/7/2016Q3 2016($0.01)ViewN/AView Earnings Details
8/8/2016Q2 2016($0.02)($0.02)ViewN/AView Earnings Details
5/9/2016Q1($0.03)($0.01)$1.70 million$1.76 millionViewN/AView Earnings Details
3/15/2016($0.01)$2.30 million$2.02 millionViewN/AView Earnings Details
8/11/2015Q2 2015($0.01)ViewN/AView Earnings Details
3/31/2015$0.01$0.01$1.92 million$1.97 millionViewN/AView Earnings Details
11/13/2014($0.02)$1.71 million$1.62 millionViewN/AView Earnings Details
5/16/2014$0.01($0.04)$1.92 million$1.32 millionViewN/AView Earnings Details
8/12/2013Q2 2013$0.02$0.01ViewN/AView Earnings Details
3/12/2013Q4 2012$0.01$0.01ViewN/AView Earnings Details
5/15/2012Q1 2012($0.03)($0.02)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

OptimizeRx (OTCMKTS:OPRX) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for OptimizeRx (OTCMKTS:OPRX)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

OptimizeRx (OTCMKTS OPRX) Insider Trading and Institutional Ownership History

Institutional Ownership Percentage: 8.05%
Insider Trades by Quarter for OptimizeRx (OTCMKTS:OPRX)

OptimizeRx (OTCMKTS OPRX) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/11/2017Douglas P BakerInsiderBuy10,000$0.77$7,700.0050,000View SEC Filing  
3/21/2017Gus D HalasDirectorBuy21,990$0.77$16,932.3074,279View SEC Filing  
12/1/2016William J FebboCEOBuy4,000$0.85$3,400.0044,000View SEC Filing  
11/14/2016Douglas P BakerInsiderBuy10,000$0.85$8,500.0040,000View SEC Filing  
11/14/2016Terrence HamiltonVPBuy7,000$0.90$6,300.00387,413View SEC Filing  
11/10/2016William J FebboInsiderBuy9,000$0.90$8,100.0040,000View SEC Filing  
6/9/2016William J FebboCEOBuy21,567$1.08$23,292.3619,433View SEC Filing  
6/8/2016James M BrooksSVPBuy10,000$1.06$10,600.0010,000View SEC Filing  
6/7/2016Douglas P BakerCFOBuy10,000$1.05$10,500.0030,000View SEC Filing  
10/6/2015Gus D HalasDirectorBuy10,000$1.26$12,600.0048,769View SEC Filing  
11/17/2014Douglas P BakerCFOBuy10,000$0.88$8,800.00View SEC Filing  
7/24/2014Bradley Louis RadoffMajor ShareholderSell631,100$1.41$889,851.00View SEC Filing  
6/5/2014Douglas P BakerCFOBuy10,000$1.50$15,000.00View SEC Filing  
6/4/2014Bradley Louis RadoffMajor ShareholderSell329,700$1.46$481,362.00View SEC Filing  
4/29/2014Terrence HamiltonDirectorSell55,000$1.60$88,000.00View SEC Filing  
4/24/2014David HarrellCEOSell552,500$1.60$884,000.00View SEC Filing  
5/28/2013Terrence HamiltonDirectorSell45,000$1.81$81,450.00View SEC Filing  
5/23/2013Terrence HamiltonDirectorSell5,000$1.60$8,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

OptimizeRx (OTCMKTS OPRX) News Headlines

Source:
DateHeadline
OptimizeRx to Present at Noble Capital Markets 14th Annual Investor Conference on January 30, 2018OptimizeRx to Present at Noble Capital Markets 14th Annual Investor Conference on January 30, 2018
finance.yahoo.com - January 16 at 10:11 AM
OptimizeRx Expands Exclusive Partnership with Allscripts for Prescription Cost Savings and Real-time Messaging at Point-of-CareOptimizeRx Expands Exclusive Partnership with Allscripts for Prescription Cost Savings and Real-time Messaging at Point-of-Care
finance.yahoo.com - January 9 at 4:46 PM
OptimizeRx to Launch Real-time Financial Messaging With Modernizing Medicine, Providing Prescription Cost Savings at Point-of-CareOptimizeRx to Launch Real-time Financial Messaging With Modernizing Medicine, Providing Prescription Cost Savings at Point-of-Care
finance.yahoo.com - December 6 at 10:28 AM
OptimizeRx Launches Real-time Financial Messaging Directly Within Another Top 20 EHR, Amazing Charts, Providing Prescription Cost Savings at Point-of-CareOptimizeRx Launches Real-time Financial Messaging Directly Within Another Top 20 EHR, Amazing Charts, Providing Prescription Cost Savings at Point-of-Care
finance.yahoo.com - November 21 at 9:01 AM
OptimizeRx Corp. :OPRX-US: Earnings Analysis: Q3, 2017 By the Numbers : November 8, 2017OptimizeRx Corp. :OPRX-US: Earnings Analysis: Q3, 2017 By the Numbers : November 8, 2017
finance.yahoo.com - November 9 at 10:26 AM
OptimizeRxs (OPRX) CEO William Febbo on Q3 2017 Results - Earnings Call TranscriptOptimizeRx's (OPRX) CEO William Febbo on Q3 2017 Results - Earnings Call Transcript
seekingalpha.com - November 4 at 8:34 AM
OptimizeRx Corp to Host Earnings CallOptimizeRx Corp to Host Earnings Call
finance.yahoo.com - November 4 at 8:34 AM
OptimizeRx Reports Third Quarter 2017 Results; Net Revenue Up 74% to Record $3.1 MillionOptimizeRx Reports Third Quarter 2017 Results; Net Revenue Up 74% to Record $3.1 Million
finance.yahoo.com - November 4 at 8:34 AM
Edited Transcript of OPRX earnings conference call or presentation 2-Nov-17 8:30pm GMTEdited Transcript of OPRX earnings conference call or presentation 2-Nov-17 8:30pm GMT
finance.yahoo.com - November 4 at 8:34 AM
OptimizeRx Corp. (OPRX) Now Covered by Lake Street CapitalOptimizeRx Corp. (OPRX) Now Covered by Lake Street Capital
www.americanbankingnews.com - October 30 at 4:36 PM
OptimizeRx Corp. (OPRX) to Release Quarterly Earnings on ThursdayOptimizeRx Corp. (OPRX) to Release Quarterly Earnings on Thursday
www.americanbankingnews.com - October 26 at 6:10 AM
OptimizeRx Sets Third Quarter 2017 Conference Call for Thursday, November 2, 2017 at 4:30 p.m. ETOptimizeRx Sets Third Quarter 2017 Conference Call for Thursday, November 2, 2017 at 4:30 p.m. ET
finance.yahoo.com - October 20 at 7:12 AM
OptimizeRx Launches Automated Financial Messaging within iSalus Healthcare’s EHR, Providing Prescriptions Cost SavingsOptimizeRx Launches Automated Financial Messaging within iSalus Healthcare’s EHR, Providing Prescriptions Cost Savings
finance.yahoo.com - October 2 at 8:44 PM
OptimizeRx Corp. :OPRX-US: Earnings Analysis: Q2, 2017 By the Numbers : September 18, 2017OptimizeRx Corp. :OPRX-US: Earnings Analysis: Q2, 2017 By the Numbers : September 18, 2017
finance.yahoo.com - September 19 at 6:14 AM
OptimizeRx to Present at Dougherty & Company Institutional Investor Conference on September 19, 2017OptimizeRx to Present at Dougherty & Company Institutional Investor Conference on September 19, 2017
finance.yahoo.com - September 13 at 7:28 AM
OptimizeRx to Lead Kick-off Panel at Distributed: Health Conference on September 25-26, 2017OptimizeRx to Lead Kick-off Panel at Distributed: Health Conference on September 25-26, 2017
feeds.benzinga.com - September 5 at 12:06 PM
OptimizeRx Corp. (OTCMKTS:OPRX) Announces  Earnings ResultsOptimizeRx Corp. (OTCMKTS:OPRX) Announces Earnings Results
www.americanbankingnews.com - August 2 at 1:02 PM
OptimizeRxs (OPRX) CEO William Febbo on Q2 2017 Results - Earnings Call TranscriptOptimizeRx's (OPRX) CEO William Febbo on Q2 2017 Results - Earnings Call Transcript
seekingalpha.com - August 2 at 6:40 AM
OptimizeRx Reports Second Quarter 2017 Results; Net Revenue Up 50% to a Record $2.9 MillionOptimizeRx Reports Second Quarter 2017 Results; Net Revenue Up 50% to a Record $2.9 Million
finance.yahoo.com - August 2 at 6:39 AM
Edited Transcript of OPRX earnings conference call or presentation 1-Aug-17 8:30pm GMTEdited Transcript of OPRX earnings conference call or presentation 1-Aug-17 8:30pm GMT
finance.yahoo.com - August 2 at 6:39 AM
OptimizeRx Appoints Health IT Industry Veteran, Miriam Paramore, as President ...OptimizeRx Appoints Health IT Industry Veteran, Miriam Paramore, as President ...
www.nasdaq.com - August 1 at 12:33 AM
OptimizeRx Appoints Health IT Industry Veteran, Miriam Paramore, as President; Paramore to Drive Scale as OptimizeRx Offers Medication Savings at Point-of-CareOptimizeRx Appoints Health IT Industry Veteran, Miriam Paramore, as President; Paramore to Drive Scale as OptimizeRx Offers Medication Savings at Point-of-Care
finance.yahoo.com - August 1 at 12:33 AM
OptimizeRx Corp. (OTCMKTS:OPRX) to Release Quarterly Earnings on TuesdayOptimizeRx Corp. (OTCMKTS:OPRX) to Release Quarterly Earnings on Tuesday
www.americanbankingnews.com - July 27 at 2:18 PM
OptimizeRx Corporation Sets Second Quarter 2017 Conference Call for Tuesday, August 1, 2017 at 4:30 p.m. ETOptimizeRx Corporation Sets Second Quarter 2017 Conference Call for Tuesday, August 1, 2017 at 4:30 p.m. ET
finance.yahoo.com - July 19 at 12:59 AM
OptimizeRxs CEO, William Febbo, Discusses Companys Digital Health Services in New SNNLive Video Interview on StockNewsNow.comOptimizeRx's CEO, William Febbo, Discusses Company's Digital Health Services in New SNNLive Video Interview on StockNewsNow.com
finance.yahoo.com - July 11 at 6:23 AM
OPTIMIZERX CORP Files SEC form 10-K, Annual ReportOPTIMIZERX CORP Files SEC form 10-K, Annual Report
biz.yahoo.com - March 8 at 8:45 PM
Q4 2016 OPTIMIZERx Corp Earnings Release - Time Not SuppliedQ4 2016 OPTIMIZERx Corp Earnings Release - Time Not Supplied
biz.yahoo.com - March 8 at 9:16 AM
OptimizeRx Corporation Sets Fourth Quarter and Full Year 2016 Conference Call for Wednesday, March 8, 2017 at 4:30 p.m. ETOptimizeRx Corporation Sets Fourth Quarter and Full Year 2016 Conference Call for Wednesday, March 8, 2017 at 4:30 p.m. ET
feeds.benzinga.com - February 22 at 8:42 AM
OptimizeRx Continues EHR Channel Partnership ExpansionOptimizeRx Continues EHR Channel Partnership Expansion
us.rd.yahoo.com - February 14 at 10:44 PM
OptimizeRx to Present at Noble Capital Markets’ 13th Annual Investor Conference on January 30, 2017OptimizeRx to Present at Noble Capital Markets’ 13th Annual Investor Conference on January 30, 2017
us.rd.yahoo.com - January 11 at 7:42 PM
OPTIMIZERX CORP Files SEC form 8-K, Change in Directors or Principal OfficersOPTIMIZERX CORP Files SEC form 8-K, Change in Directors or Principal Officers
biz.yahoo.com - December 6 at 9:32 AM
OptimizeRxs (OPRX) CEO William Febbo on Q3 2016 Results - Earnings Call TranscriptOptimizeRx's (OPRX) CEO William Febbo on Q3 2016 Results - Earnings Call Transcript
seekingalpha.com - November 11 at 6:26 PM
OPTIMIZERX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial StatementsOPTIMIZERX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Statements
biz.yahoo.com - November 9 at 6:36 PM
Q3 2016 OPTIMIZERx Corp Earnings Release - Time Not SuppliedQ3 2016 OPTIMIZERx Corp Earnings Release - Time Not Supplied
biz.yahoo.com - November 7 at 10:30 AM
OPTIMIZERX CORP Files SEC form 8-K, Other Events, Financial Statements and ExhibitsOPTIMIZERX CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits
biz.yahoo.com - September 23 at 6:07 PM
Q2 2016 OPTIMIZERx Corp Earnings Release - Time Not SuppliedQ2 2016 OPTIMIZERx Corp Earnings Release - Time Not Supplied
biz.yahoo.com - August 8 at 11:20 AM
OPTIMIZERX CORP Files SEC form 10-Q, Quarterly ReportOPTIMIZERX CORP Files SEC form 10-Q, Quarterly Report
biz.yahoo.com - May 9 at 4:40 PM
Q1 2016 Optimizerx Corp Earnings Release - Time Not SuppliedQ1 2016 Optimizerx Corp Earnings Release - Time Not Supplied
biz.yahoo.com - May 9 at 7:07 AM

SEC Filings

OptimizeRx (OTCMKTS:OPRX) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

OptimizeRx (OTCMKTS OPRX) Stock Chart for Tuesday, January, 16, 2018

Loading chart…

This page was last updated on 1/16/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.